The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study

Int J Mol Sci. 2023 Feb 17;24(4):4071. doi: 10.3390/ijms24044071.

Abstract

Diagnosis of interstitial lung diseases (ILD) is difficult to perform. Extracellular vesicles (EVs) facilitate cell-to-cell communication, and they are released by a variety of cells. Our goal aimed to investigate EV markers in bronchoalveolar lavage (BAL) from idiopathic pulmonary fibrosis (IPF), sarcoidosis and hypersensitivity pneumonitis (HP) cohorts. ILD patients followed at Siena, Barcelona and Foggia University Hospitals were enrolled. BAL supernatants were used to isolate the EVs. They were characterized by flow cytometry assay through MACSPlex Exsome KIT. The majority of alveolar EV markers were related to the fibrotic damage. CD56, CD105, CD142, CD31 and CD49e were exclusively expressed by alveolar samples from IPF patients, while HP showed only CD86 and CD24. Some EV markers were common between HP and sarcoidosis (CD11c, CD1c, CD209, CD4, CD40, CD44, CD8). Principal component analysis distinguished the three groups based on EV markers with total variance of 60.08%. This study has demonstrated the validity of the flow cytometric method to phenotype and characterize EV surface markers in BAL samples. The two granulomatous diseases, sarcoidosis and HP, cohorts shared alveolar EV markers not revealed in IPF patients. Our findings demonstrated the viability of the alveolar compartment allowing identification of lung-specific markers for IPF and HP.

Keywords: bronchoalveolar lavage; diagnosis; extracellular vesicles; idiopathic pulmonary fibrosis; interstitial lung diseases.

Publication types

  • Multicenter Study

MeSH terms

  • Alveolitis, Extrinsic Allergic / diagnosis
  • Biomarkers / analysis
  • Bronchoalveolar Lavage Fluid* / chemistry
  • Extracellular Vesicles* / chemistry
  • Humans
  • Idiopathic Pulmonary Fibrosis / diagnosis
  • Lung Diseases, Interstitial* / diagnosis
  • Sarcoidosis / diagnosis

Substances

  • Biomarkers

Grants and funding

This research received no external funding.